Bayer AG is a life science company with a focus on healthcare and nutrition. The company operates through three segments – Pharmaceuticals, Consumer Health, and Crop Science. The Pharmaceuticals segment concentrates on prescription products, especially for cardiology and women’s healthcare, and on speciality therapeutics with a focus on oncology, haematology, ophthalmology, and cell and gene therapy. It established a strategic unit for cell and gene therapy covering the entire value creation chain from research and development to marketing and patients. This division also comprises the radiology business, which markets diagnostic imaging equipment and digital solutions. The Consumer Health segment supplies non-prescription medicines, nutritional supplements, medicated skincare products, and other self-care solutions in the categories of pain, cardiovascular risk prevention, dermatology, digestive health, allergy, and cough and cold. The Crop Science segment is an agriculture enterprise, with businesses in crop protection, seeds and traits, and digital farming. It offers a portfolio of high-value seeds, improved plant traits, innovative chemical and biological crop protection products, digital solutions, and customer service for sustainable agriculture.

The major products of Bayer include Roundup, Adengo, Alion, Corvus, Atlantis, XtendiMax, Fox, Luna, Nativo, Serenade, Xpro, Delaro Complete, Prosaro, BioAct, Confidor, Movento, Sivanto, Vayego, Velum/Verango, and Vynyty Citrus. Bayer conducts research in the field of health and agriculture through collaboration with researchers. The company uses its innovative solutions to respond to the global challenges in healthcare and the need to safeguard an adequate food supply.